Searched for
ARCH PHARMALABS
NCLT rejects JM Financial Asset Reconstruction's plea in Arch Pharmalabs case...The National Company Law Tribunal dismissed JM Financial Asset Reconstruction's application to intervene in an insolvency resolution applic...- Banks sell portion of Arch pharma’s Rs 3,000-crore loan at half the valueThe Corporate Debt Restructuring Proposal was referred to the CDR cell in May 2013 after Arch Pharma Labs was struggling under a debt burde...
- CCI approves Mitsui's 26% stake buy in Arch PharmalabsCompetition Commission of India (CCI) has approved Japanese firm Mitsui's proposed takeover of 26.71 per cent stake in domestic biopharmace...
- Mitsui & Co buys additional 25% stake in Arch Pharmalabs for Rs 372 croreMitsui is buying out the stakes of IL&FS Trust Co, IDBI Trusteeship Services and Rainbow Fund, according to an application to the FIPB.
- Mitsui acquires 5% in Arch PharmaDiversified Japanese conglomerate Mitsui has bought a 5% stake in Arch Pharmalabs for around Rs 65 crore.
- Funds see big gains in exitsMore private equity and venture capital-funded companies will float IPOs in the coming weeks as valuations soar and investors look to rake ...
- PE & VC-funded cos line up public offersMore PE and venture capital-funded cos will float IPOs in the coming weeks as valuations soar and investors look to rake in profits.
- Mid-cap pharma firms focus on LatAm marketLupin and Glenmark Pharmaceuticals are leading Indian mid-cap drug makers in exploiting rising demand for medicines in South American natio...
- Arch Pharmalabs becomes a leading API makerBorn out of an ailing pharma company, Arch Pharmalabs is now a leading API maker.
- Arch Pharma buys Benzochem for Rs 100 crPrivate equity-controlled Arch Pharmalabs has acquired a controlling stake in Benzochem Lifesciences, an active pharmaceutical ingredients ...
- Arch Pharmalabs signs MoU with France-based Texcell SADrug firm Arch Pharmalabs on Thursday said it has signed a memorandum of understanding with France-based Texcell SA for providing immunolog...
- Arch Pharmalabs Ltd changing horizonsThe entrepreneurial bug bit him at a very young age of 22 and the outcome was a financial services company. In 1998 his life changed track,...
- Arch Pharmalabs looking at takeovers in EuropeAfter strengthening its foothold on the home turf, active pharmaceutical ingredient (API) manufacturer Arch Pharmlabs is looking for takeov...
- Arch Pharma to buy out promoters in Hyderabad company AvonArch Pharmalabs, which recently acquired a 43% stake in Hyderabad-based pharma company Avon Organics, will raise its stake to a majority by...
- Arch Pharmalabs in manufacturing tie-up with DSMArch Pharmalabs expects to earn $100 million by 2010 from the bulk drug manufacturing deal it has entered into with chemicals group DSM, an...
- DSM Anti Infectives, Arch in strategic pactGlobal multispeciality chemical company, DSM has entered into a manufacturing agreement with pharma major Arch Pharmalabs for manufacturing...
- Arch Pharmalabs acquires 42 pc of Avon OrganicsMumbai-based Arch Pharmalabs on Sunday said it is acquiring 42 per cent stake in BSE-listed Avon Organics for Rs 20 crore.
- Arch Pharmalabs acquires Watsol OrganicsCrug maker Arch Pharmalabs has acquired Watsol Organics for Rs 30 crore.
- Arch Pharma plans to raise Rs 100 crore private equityArch Pharmalabs, a Rs 246-crore Mumbai-based active pharmaceutical ingredient (API) manufacturer, is close to raising Rs 100 crore through ...
- Arch Pharmalabs to raise Rs 100 cr via pvt placementArch Pharmalabs, a Rs 246-crore Mumbai-based active pharmaceutical ingredient (API) maker, is close to raising Rs 100 crore through private...
Load More- Mitsui & Co buys additional 25% stake in Arch Pharmalabs for Rs 372 crore
